These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 29748024)
1. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer. Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024 [TBL] [Abstract][Full Text] [Related]
2. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma. Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550 [TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma. Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655 [TBL] [Abstract][Full Text] [Related]
4. Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer. Okamura K; Harada T; Wang S; Ijichi K; Furuyama K; Koga T; Okamoto T; Takayama K; Yano T; Nakanishi Y Lung Cancer; 2012 Oct; 78(1):100-6. PubMed ID: 22906736 [TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807 [TBL] [Abstract][Full Text] [Related]
6. Autocrine activity of BDNF induced by the STAT3 signaling pathway causes prolonged TrkB activation and promotes human non-small-cell lung cancer proliferation. Chen B; Liang Y; He Z; An Y; Zhao W; Wu J Sci Rep; 2016 Jul; 6():30404. PubMed ID: 27456333 [TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer. Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982 [TBL] [Abstract][Full Text] [Related]
8. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer. Yuan Y; Ye HQ; Ren QC Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer. Yuan Y; Ye HQ; Ren QC Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295 [TBL] [Abstract][Full Text] [Related]
10. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells. Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771 [TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Okugawa Y; Tanaka K; Inoue Y; Kawamura M; Kawamoto A; Hiro J; Saigusa S; Toiyama Y; Ohi M; Uchida K; Mohri Y; Kusunoki M Br J Cancer; 2013 Jan; 108(1):121-30. PubMed ID: 23175149 [TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of brain-derived neurotrophic factors and receptors in multiple myeloma]. Sun CY; Hu Y; Wu T; Wang YD; He WJ Zhonghua Nei Ke Za Zhi; 2005 Dec; 44(12):906-9. PubMed ID: 16409727 [TBL] [Abstract][Full Text] [Related]
13. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis. Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409 [TBL] [Abstract][Full Text] [Related]
14. TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. Zhang S; Guo D; Luo W; Zhang Q; Zhang Y; Li C; Lu Y; Cui Z; Qiu X BMC Cancer; 2010 Feb; 10():43. PubMed ID: 20156366 [TBL] [Abstract][Full Text] [Related]
15. Neurotrophin system activation in pleural effusions. Ricci A; Mariotta S; Pompili E; Mancini R; Bronzetti E; De Vitis C; Pisani L; Cherubini E; Bruno P; Gencarelli G; Giovagnoli MR; Terzano C; Ciliberto G; Giarnieri E; Fumagalli L Growth Factors; 2010 Aug; 28(4):221-31. PubMed ID: 20214505 [TBL] [Abstract][Full Text] [Related]
16. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases. Contreras-Zárate MJ; Day NL; Ormond DR; Borges VF; Tobet S; Gril B; Steeg PS; Cittelly DM Oncogene; 2019 Jun; 38(24):4685-4699. PubMed ID: 30796353 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog Inhibition Upregulates TRK Expression to Antagonize Tumor Suppression in Small Cell Lung Cancer Cells. Onishi H; Nakamura K; Nagai S; Yanai K; Yamasaki A; Kawamoto M; Imaizumi A; Morisaki T Anticancer Res; 2017 Sep; 37(9):4987-4992. PubMed ID: 28870922 [TBL] [Abstract][Full Text] [Related]
18. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer. Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707 [TBL] [Abstract][Full Text] [Related]
19. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. Oyama Y; Nagao S; Na L; Yanai K; Umebayashi M; Nakamura K; Nagai S; Fujimura A; Yamasaki A; Nakayama K; Morisaki T; Onishi H Anticancer Res; 2021 Aug; 41(8):4047-4052. PubMed ID: 34281873 [TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Li Z; Jaboin J; Dennis PA; Thiele CJ Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]